Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity.

scientific article

Expression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3324/HAEMATOL.12171
P698PubMed publication ID18443272
P5875ResearchGate publication ID5409639

P50authorJuan C MonteroQ56811309
Ricardo López-PérezQ74673991
Atanasio PandiellaQ83446572
Jesús San MiguelQ5930658
P433issue6
P921main subjectmultiple myelomaQ467635
P304page(s)851-859
P577publication date2008-04-28
P1433published inHaematologicaQ5638209
P1476titleExpression of c-Kit isoforms in multiple myeloma: differences in signaling and drug sensitivity
P478volume93

Reverse relations

cites work (P2860)
Q39650027A meta-analysis of prognostic value of KIT mutation status in gastrointestinal stromal tumors
Q38190971Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma
Q41360812Autocrine insulin-like growth factor 1 and stem cell factor but not interleukin 6 support self-renewal of human myeloma cells
Q34543082CD117 expression in gammopathies is associated with an altered maturation of the myeloid and lymphoid hematopoietic cell compartments and favorable disease features
Q92669995Clinical prognostic implications of EPB41L4A expression in multiple myeloma
Q35058356Discovery and development of small molecule SHIP phosphatase modulators
Q36959863Emerging functions of c-kit and its ligand stem cell factor in dendritic cells: regulators of T cell differentiation
Q34924515High-resolution kinetics of cytokine signaling in human CD34/CD117-positive cells in unfractionated bone marrow
Q38641261Immunophenotype of normal and myelomatous plasma-cell subsets
Q37276382KIT GNNK splice variants: expression in systemic mastocytosis and influence on the activating potential of the D816V mutation in mast cells
Q37340398New targets and treatments in multiple myeloma: Src family kinases as central regulators of disease progression
Q33416297Recent advances in antimultiple myeloma drug development
Q36811035Signaling of c-kit in dendritic cells influences adaptive immunity
Q38922393The Assessment of CD56 and CD117 Expressions at the Time of the Diagnosis in Multiple Myeloma Patients
Q38264052The SCF/c-KIT system in the male: Survival strategies in fertility and cancer
Q37641380The role of ancestim (recombinant human stem-cell factor, rhSCF) in hematopoietic stem cell mobilization and hematopoietic reconstitution
Q39401758The stem cell factor (SCF)/c-KIT signalling in testis and prostate cancer
Q35718988Therapeutic potential of SH2 domain-containing inositol-5'-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer
Q44004521Transcriptomic rationale for the synergy observed with dasatinib + bortezomib + dexamethasone in multiple myeloma

Search more.